![[Station R] Testmate Health boucle un projet Innosuisse à CHF 890’000](https://republic-of-innovation.ch/wordpress/wp-content/uploads/2021/02/testmate-630x317.jpg)
Testmate Health (ribolifeDx SA), with their research partners, has been awarded 890,000 CHF of non-dilutive funding from Innosuisse (Swiss Innovation Agency) to develop smartphone compatible at home self-testing kits for sexually transmitted diseases.
This funding supports the development & pre-clinical validation of Testmate Health’s final prototype with CSEM (Swiss Center for Electronics & Microtechnology) and HUG – Hopitaux Universitaires de Genève (University Hospital of Geneva).
In 2020, consumers learnt to take control over their health by moving toward home-based & digital solutions. Testmate Health is
building on rapidly changing shifts in behaviour by delivering an anonymous & convenient option for self-testing anywhere, anytime. Our first test is a multiplexed test for the 4 common sexually transmitted diseases with further tests in the pipeline.